Vimarsana
Biggest News Aggregation in the World

Computational Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Computational Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Computational Oncology Today - Breaking & Trending Today

Using Biomechanistic Modeling, Researchers Predict Prostate Cancer Growth - Vimarsana News

Using Biomechanistic Modeling, Researchers Predict Prostate Cancer Growth

Guillermo Lorenzo, postdoctoral researcher at the Oden Institute, recently published a paper regarding a framework to forecast the development and growth of tumors found in prostate cancer, providing personalized predictions to patients and clinicians. 

Source: utexas.edu
Predicting Prostate Cancer Growth Through Biomechanistic Modeling - Vimarsana News

Predicting Prostate Cancer Growth Through Biomechanistic Modeling

Prostate cancer is an exceedingly common disease, affecting 1 in 8 men. When diagnosed early, many can live for years without symptoms. Rather than subject early-disease stage patients to the debilitating side-effects of radiation and surgery, clinic

From Average to Individual: Transforming Cancer Care With Single-Subject Clinical Trials - Vimarsana News

From Average to Individual: Transforming Cancer Care With Single-Subject Clinical Trials

Read about the Center for Computational Oncology's work with the MD Anderson Cancer Center to design clinical trials for patients who are not average. 

Source: utexas.edu
Had COVID-19 But Your Friend Didn't? Why the Difference? - Vimarsana News

Had COVID-19 But Your Friend Didn't? Why the Difference?

Investigators in the Department of Computational Biomedicine at Cedars-Sinai wanted to find out which factors influenced susceptibility to COVID-19 infection an

Had COVID-19 But Your Friend Didn't? Why the Difference? - Vimarsana News

Had COVID-19 But Your Friend Didn't? Why the Difference?

Investigators in the Department of Computational Biomedicine at Cedars-Sinai wanted to find out which factors influenced susceptibility to COVID-19 infection an